BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 26504261)

  • 21. Ehlers-Danlos syndrome type VIII.
    Nelson DL; King RA
    J Am Acad Dermatol; 1981 Sep; 5(3):297-303. PubMed ID: 7263975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A study of migraine characteristics in joint hypermobility syndrome a.k.a. Ehlers-Danlos syndrome, hypermobility type.
    Puledda F; Viganò A; Celletti C; Petolicchio B; Toscano M; Vicenzini E; Castori M; Laudani G; Valente D; Camerota F; Di Piero V
    Neurol Sci; 2015 Aug; 36(8):1417-24. PubMed ID: 25791889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastrointestinal and nutritional issues in joint hypermobility syndrome/Ehlers-Danlos syndrome, hypermobility type.
    Castori M; Morlino S; Pascolini G; Blundo C; Grammatico P
    Am J Med Genet C Semin Med Genet; 2015 Mar; 169C(1):54-75. PubMed ID: 25821092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tenascin-X, collagen, and Ehlers-Danlos syndrome: tenascin-X gene defects can protect against adverse cardiovascular events.
    Petersen JW; Douglas JY
    Med Hypotheses; 2013 Sep; 81(3):443-7. PubMed ID: 23830591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between fatigue and gait abnormality in joint hypermobility syndrome/Ehlers-Danlos syndrome hypermobility type.
    Celletti C; Galli M; Cimolin V; Castori M; Albertini G; Camerota F
    Res Dev Disabil; 2012; 33(6):1914-8. PubMed ID: 22819599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ehlers-Danlos type VIII, periodontitis-type: further delineation of the syndrome in a four-generation pedigree.
    Reinstein E; Wang RY; Zhan L; Rimoin DL; Wilcox WR
    Am J Med Genet A; 2011 Apr; 155A(4):742-7. PubMed ID: 21594996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The multifaceted and complex hypermobility syndrome (a.k.a. Ehlers-Danlos Syndrome Hypermobility Type): evaluation and management through a rehabilitative approach.
    Celletti C; Camerota F
    Clin Ter; 2013; 164(4):e325-35. PubMed ID: 24045532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low tendon stiffness and abnormal ultrastructure distinguish classic Ehlers-Danlos syndrome from benign joint hypermobility syndrome in patients.
    Nielsen RH; Couppé C; Jensen JK; Olsen MR; Heinemeier KM; Malfait F; Symoens S; De Paepe A; Schjerling P; Magnusson SP; Remvig L; Kjaer M
    FASEB J; 2014 Nov; 28(11):4668-76. PubMed ID: 25122555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spectrum of Gastrointestinal Manifestations in Joint Hypermobility Syndromes.
    Botrus G; Baker O; Borrego E; Ngamdu KS; Teleb M; Gonzales Martinez JL; Maldonado G; Hussein AM; McCallum R
    Am J Med Sci; 2018 Jun; 355(6):573-580. PubMed ID: 29891041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Musculocontractural Ehlers-Danlos Syndrome (former EDS type VIB) and adducted thumb clubfoot syndrome (ATCS) represent a single clinical entity caused by mutations in the dermatan-4-sulfotransferase 1 encoding CHST14 gene.
    Malfait F; Syx D; Vlummens P; Symoens S; Nampoothiri S; Hermanns-Lê T; Van Laer L; De Paepe A
    Hum Mutat; 2010 Nov; 31(11):1233-9. PubMed ID: 20842734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Foot type analysis based on electronic pedobarography data in individuals with joint hypermobility syndrome/Ehlers-Danlos syndrome hypermobility type during upright standing.
    Cimolin V; Galli M; Celletti C; Pau M; Castori M; Morico G; Albertini G; Camerota F
    J Am Podiatr Med Assoc; 2014 Nov; 104(6):588-93. PubMed ID: 25514270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neurodevelopmental attributes of joint hypermobility syndrome/Ehlers-Danlos syndrome, hypermobility type: Update and perspectives.
    Ghibellini G; Brancati F; Castori M
    Am J Med Genet C Semin Med Genet; 2015 Mar; 169C(1):107-16. PubMed ID: 25654988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Periodontal Ehlers-Danlos Syndrome Is Caused by Mutations in C1R and C1S, which Encode Subcomponents C1r and C1s of Complement.
    Kapferer-Seebacher I; Pepin M; Werner R; Aitman TJ; Nordgren A; Stoiber H; Thielens N; Gaboriaud C; Amberger A; Schossig A; Gruber R; Giunta C; Bamshad M; Björck E; Chen C; Chitayat D; Dorschner M; Schmitt-Egenolf M; Hale CJ; Hanna D; Hennies HC; Heiss-Kisielewsky I; Lindstrand A; Lundberg P; Mitchell AL; Nickerson DA; Reinstein E; Rohrbach M; Romani N; Schmuth M; Silver R; Taylan F; Vandersteen A; Vandrovcova J; Weerakkody R; Yang M; Pope FM; ; Byers PH; Zschocke J
    Am J Hum Genet; 2016 Nov; 99(5):1005-1014. PubMed ID: 27745832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic linkage to the collagen alpha 1 (V) gene (COL5A1) in two British Ehlers-Danlos syndrome families with variable type I and II phenotypes.
    Burrows NP; Nicholls AC; Yates JR; Richards AJ; Pope FM
    Clin Exp Dermatol; 1997 Jul; 22(4):174-6. PubMed ID: 9499606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Understanding the basis of Ehlers-Danlos syndrome in the era of the next-generation sequencing.
    Cortini F; Villa C; Marinelli B; Combi R; Pesatori AC; Bassotti A
    Arch Dermatol Res; 2019 May; 311(4):265-275. PubMed ID: 30826961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of consensus on tests and criteria for generalized joint hypermobility, Ehlers-Danlos syndrome: hypermobile type and joint hypermobility syndrome.
    Remvig L; Flycht L; Christensen KB; Juul-Kristensen B
    Am J Med Genet A; 2014 Mar; 164A(3):591-6. PubMed ID: 24464988
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of narrative medicine in the management of joint hypermobility syndrome/Ehlers-Danlos syndrome, hypermobility type.
    Knight I
    Am J Med Genet C Semin Med Genet; 2015 Mar; 169C(1):123-9. PubMed ID: 25821096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ehlers-Danlos syndrome with lethal cardiac valvular dystrophy in males carrying a novel splice mutation in FLNA.
    Ritelli M; Morlino S; Giacopuzzi E; Carini G; Cinquina V; Chiarelli N; Majore S; Colombi M; Castori M
    Am J Med Genet A; 2017 Jan; 173(1):169-176. PubMed ID: 27739212
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Joint hypermobility syndrome (a.k.a. Ehlers-Danlos Syndrome, Hypermobility Type): an updated critique.
    Castori M
    G Ital Dermatol Venereol; 2013 Feb; 148(1):13-36. PubMed ID: 23407074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autonomic symptom burden in the hypermobility type of Ehlers-Danlos syndrome: a comparative study with two other EDS types, fibromyalgia, and healthy controls.
    De Wandele I; Calders P; Peersman W; Rimbaut S; De Backer T; Malfait F; De Paepe A; Rombaut L
    Semin Arthritis Rheum; 2014 Dec; 44(3):353-61. PubMed ID: 24968706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.